615 related articles for article (PubMed ID: 18064767)
1. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2007 Nov; 72(230):67639-40. PubMed ID: 18064767
[TBL] [Abstract][Full Text] [Related]
2. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Aug; 65(148):46864-8. PubMed ID: 11067707
[TBL] [Abstract][Full Text] [Related]
3. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2005 Oct; 70(195):58974-7. PubMed ID: 16217879
[TBL] [Abstract][Full Text] [Related]
4. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
[TBL] [Abstract][Full Text] [Related]
6. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule.
Fed Regist; 2006 Aug; 71(147):83358[sic., should be 43358]-63. PubMed ID: 16892519
[TBL] [Abstract][Full Text] [Related]
7. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final monograph for combination drug products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Dec; 67(246):78158-72. PubMed ID: 12508820
[TBL] [Abstract][Full Text] [Related]
8. Labeling for bronchodilators to treat asthma; cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2011 Jul; 76(143):44475-89. PubMed ID: 21796845
[TBL] [Abstract][Full Text] [Related]
9. Skin protectant drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2003 Dec; 68(236):68509-11. PubMed ID: 14664244
[TBL] [Abstract][Full Text] [Related]
10. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; partial final rule for combination drug products containing a bronchodilator. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2001 Sep; 66(188):49276-8. PubMed ID: 11758596
[TBL] [Abstract][Full Text] [Related]
11. Astringent drug products that produce aluminum acetate; skin protectant drug products for over-the-counter human use; technical amendment. Final rule; technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2009 Mar; 74(43):9759-65. PubMed ID: 19418638
[TBL] [Abstract][Full Text] [Related]
12. Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(114):35290-3. PubMed ID: 12807133
[TBL] [Abstract][Full Text] [Related]
13. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Feb; 67(27):5942-3. PubMed ID: 11837282
[TBL] [Abstract][Full Text] [Related]
14. Labeling of diphenhydramine-containing drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Dec; 67(235):72555-9. PubMed ID: 12474879
[TBL] [Abstract][Full Text] [Related]
15. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
[TBL] [Abstract][Full Text] [Related]
16. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971
[TBL] [Abstract][Full Text] [Related]
17. Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Dec; 68(250):75414-8. PubMed ID: 14986677
[TBL] [Abstract][Full Text] [Related]
18. Antidiarrheal drug products for over-the-counter human use; amendment of final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 May; 69(92):26301-2. PubMed ID: 15141675
[TBL] [Abstract][Full Text] [Related]
19. Drug labeling; sodium labeling for over-the-counter drugs. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Nov; 69(228):69278-80. PubMed ID: 15570675
[TBL] [Abstract][Full Text] [Related]
20. Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 May; 64(98):27666-93. PubMed ID: 10558542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]